---
title: AustinPx vs Codis
slug_a: austinpx
slug_b: codis
site: cdmo
review_signal_gate: closed
canonical_path: /compare/austinpx/codis
generated_by: BioBM Editorial AI
---

# AustinPx vs Codis

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

AustinPx (austinpx) is listed for cdmo. Fee-for-service CDMO specializing in formulation development, process development, and GMP manufacturing of oral dosage forms from preclinical through Phase II, with proprietary KinetiSol amorphous solid dispersion technology for poorly soluble APIs.

Services: 7. Modalities: 1. Indications: 0. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Codis (codis) is listed for cdmo. Global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions, microencapsulation, and continuous granulation with 400,000 sq ft of GMP manufacturing across US and UK facilities.

Services: 8. Modalities: 1. Indications: 0. Locations: 5. Certifications: 2. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.